Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
Part of paid clinical trials in Denver, Colorado.
- Sponsor
- San Raffaele University
- Study ID
- NCT05732623
- Status
- Recruiting
Conditions
- Colorectal Cancer
- Diet Habit
- Early Onset Colorectal Cancer
- Risk Reduction
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 49 Years
- Healthy Volunteers
- Accepted
Interventions
- Semi Quantitative Food Frequency Questionnaire (SQFFQ) — BEHAVIORALThe SQFFQ quantifies the frequency of consumption of each food and drink and the following list of variables: * date of birth * sex * ethnicity * weight (kg) * height (m) * BMI (kg/m2) at the time of eoCRC diagnosis and at 18 years old * country where they live permanently * tobacco smoking at the time of eoCRC diagnosis and at 18 years old * sitting time * TV-viewing time * moderate-to-vigorous physical activity (MVPA) * waist circumference (cm) * home blood pressure levels (mmHg) * fasting blood glucose (mg/dl) * regular consumption of aspirin/NSAID and years of consumptions * calcium and folate supplements and years of consumptions * oral contraceptive agents and years of consumptions * post-menopausal hormones and years of consumptions
Study Details
An increase in early-onset colorectal cancers (eoCRC), defined as a CRC before 50 years, is confirmed globally. CRC pathogenesis has been associated with several risk factors (family history, germline pathogenic variants, obesity, alcohol, physical activity, red meat, and a Western diet). Design: an international, multicenter, retrospective case-control study of prospectively enrolled patients; low-risk intervention study as it will perform a fecal occult blood test Endpoint: predictive power of a semi-quantitative food frequency questionnaire (SQFFQ) developed for eoCRC. Cases: Patients with a recent diagnosis of eoCRC (within 2 years from enrollment). Controls: matched by age (matching range ± 5 years) and sex. Healthy volunteers will be mainly enrolled among workers within the participating hospital center. The enrolled healthy volunteers will perform a fecal occult blood test. Variables of interest: age, sex, ethnicity, BMI at the time of eoCRC diagnosis and at 18 years old, country, tobacco smoking at the time of eoCRC diagnosis and at 18 years old, sitting time, TV-viewing time, moderate-to-vigorous physical activity (MVPA), waist circumference (cm), home blood pressure levels (mmHg), fasting blood glucose (mg/dl), regular consumption of aspirin/NSAID, calcium and folate supplements, oral contraceptive agents, post-menopausal hormones and years of consumptions, if the filled questionnaire reflects diet for the last 5-10 years before. Cases only: date of eoCRC diagnosis, symptoms at diagnosis, eoCRC localization, eoCRC stage, histological diagnosis, type of surgery, and date (if performed), chemotherapy and radiotherapy (if performed), vital status and duration of follow-up, family history of CRC and other cancers (uterus, ovary, stomach, small intestine, urinary tract/bladder/kidney, bile ducts, brain, pancreas, skin tumors), type of germline pathogenetic variant (if performed). Before the case-control study, three non-consecutive 24-hour Dietary Recalls (24hDRs) will validate the SQFFQ. The SQFFQ will be administered to the validation study group during three non-consecutive calls, including one non-weekday (30-minute 24-h-recall computer-aided personal interview). Primary Objective To measure the relative risk of specific dietary and lifestyle factors (smoking habit, alcohol intake, physical activity) for early-onset colorectal cancer in countries where eoCRC incidence is increasing versus stable/decreasing
Key Dates
- Start date
- Dec 5, 2022
- Status verified
- Apr 2026
- Primary completion
- Jan 31, 2030
- Completion
- Jan 31, 2035
Study Design
- Enrollment
- 2,300 participants (estimated)
Arms
- Arm: Early onset colorectal cancerPatients with colorectal cancer diagnosed before the age of 50 years
- Arm: ControlIndividuals meeting all the following: * aged \<50 years * no history of colorectal cancer * at least one negative screening test (at least a fecal occult blood test with high sensitivity)
Primary Outcome Measure
Diet and the risk of eoCRC [ Time Frame: 10 years ]
Central Contacts
- Giulia Martina Cavestro, MD PhD0226435508
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Department of Medicine-Gastroenterology, Denver Veterans Affairs Medical Center, University of Colorado Hospital | Denver | Colorado | 80045 | Swati Patel |
| Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine University of Chicago Medicine | Chicago | Illinois | 60637 | Sonia Kupfer |
Find similar trials in Denver, CO
Related Studies
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California
- Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsPHASE1/PHASE2 · Recruiting · IDEAYA Biosciences · Los Angeles, California
- Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal CancerRecruiting · Wake Forest University Health Sciences · Millville, Delaware
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)PHASE1/PHASE2 · Recruiting · PMV Pharmaceuticals, Inc · Irvine, California